Osteoinductive potential of recombinant BMP-9 in bone defects of mice treated with antiresorptive agents.
BMP-9
antiresorptive agents
bone morphogenetic proteins
bone regeneration
denosumab
Journal
International journal of oral and maxillofacial surgery
ISSN: 1399-0020
Titre abrégé: Int J Oral Maxillofac Surg
Pays: Denmark
ID NLM: 8605826
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
12
02
2021
revised:
19
05
2021
accepted:
12
08
2021
pubmed:
30
8
2021
medline:
15
3
2022
entrez:
29
8
2021
Statut:
ppublish
Résumé
The aim of the present study was to investigate the effects of recombinant human (rh)BMP-9 on bone regenerative potential in a mouse model of antibody-mediated antiresorptive therapy (AMART). A monoclonal anti-murine receptor activator of nuclear factor-kappa B ligand (RANKL) antibody (mAb) was used to create an AMART model in mice. rhBMP-9 combined with collagen membrane was implanted in calvarial defects in mAb-treated mice. After 4 weeks, the bone formative potential in the defects was evaluated by micro-computed tomography and histological approaches. The groups implanted with rhBMP-9-containing collagen membranes demonstrated substantial osteopromotive potential, with significantly greater new bone volume (Sham + BMP-9 group; 0.86 ± 0.29 mm
Identifiants
pubmed: 34454793
pii: S0901-5027(21)00289-7
doi: 10.1016/j.ijom.2021.08.014
pii:
doi:
Substances chimiques
Bone Density Conservation Agents
0
Bone Morphogenetic Protein 2
0
Growth Differentiation Factor 2
0
Recombinant Proteins
0
Transforming Growth Factor beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
566-575Informations de copyright
Copyright © 2021 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.